TECAN GROUP AG NAMENS-AKTIEN SF/ CH0012100191 /
20/05/2024 14:23:55 | Var.+0.80 | Denaro14:23:55 | Lettera14:23:55 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
336.00EUR | +0.24% | 336.00 Quantità in denaro: - |
341.20 Quantità in lettera: - |
- | - - | - | - |
GlobeNewswire
14:20
Gray Television Commences Cash Tender Offer for Its 5.875% Senior Notes Due 2026
GlobeNewswire
14:10
Launch Your Merch FREE 4-Day Challenge Empowers Entrepreneurs to Build Profitable Merch Stores Onlin...
GlobeNewswire
14:05
Bridger Aerospace Responds to Concerns Over Politically Motivated Attacks on its Business
GlobeNewswire
14:05
NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Diseas...
GlobeNewswire
14:01
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant Inducement, Pric...
GlobeNewswire
14:01
BPMC Alert: The Law Firm of Andrews & Springer LLC Is Investigating Blueprint Medicines Corporation ...
GlobeNewswire
14:01
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for it...
GlobeNewswire
14:00
Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Perio...
GlobeNewswire
14:00
Infinera to Participate in J.P. Morgan’s 2024 Global Technology, Media and Communications Conference
GlobeNewswire
14:00
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Tes...
GlobeNewswire
14:00
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO ...
GlobeNewswire
14:00
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...
GlobeNewswire
14:00
Spinogenix Announces U.S. FDA Orphan Drug Designation Granted to SPG601 for the Treatment of Fragile...
GlobeNewswire
14:00
PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors
GlobeNewswire
14:00
PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foo...